6/17
09:05 am
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $45.00 price target on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $45.00 price target on the stock.
6/17
09:05 am
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $45.00 price target on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $45.00 price target on the stock.
6/17
08:19 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
6/17
08:19 am
ptgx
Rating for PTGX
Low
Report
Rating for PTGX
6/14
01:30 pm
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
5/9
03:39 pm
ptgx
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
5/8
02:08 pm
ptgx
Rating for PTGX
Medium
Report
Rating for PTGX
5/8
02:08 pm
ptgx
Rating for PTGX
Medium
Report
Rating for PTGX